Search results
‘Bald Ballerina’ with Stage 4 cancer inspires new generation of dancers
The Baltimore Banner· 2 hours ago“Play Disney classics!” one student shouted in response to the dance instructor’s question about...
Carefully Designing De-escalation Trials in Breast Cancer
Medscape· 1 day agoDe-escalation trials in early breast cancer are "critical to preserving quality of life" but require...
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Digital Journal· 7 days ago83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression ...
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks via Yahoo Finance· 2 days agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days ago- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with ...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 7 days agoWith its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A recent report from ...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 7 days agoShanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers ...
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and...
FOX 59 Indianapolis· 7 days agoLunit will present detailed findings on several innovative studies, including the identification of HER2 ultra-low expression in breast cancer using AI-based ...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 2 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
Mom, 33, worried for years her mole was cancer. Doctors dismissed it. Her 2-year-old saved her
TODAY via Yahoo News· 2 days agoDoctors dismissed mole on mom's wrist that her toddler pointed out. It was stage 2 melanoma. She's...